Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Cheryl, Dale"'
Autor:
Mia J, Biondi, Cheryl, Dale
Publikováno v:
American family physician. 106(6)
Publikováno v:
Annals of Hepatology, Vol 10, Iss 2, Pp 239-240 (2011)
Externí odkaz:
https://doaj.org/article/50df752fa9b447aead94709429ccd4a3
Autor:
Cheryl Dale
Publikováno v:
Gastroenterology Nursing. 39:12-16
Gastric varices can occur in as many as one-third of patients with portal hypertension. Within the nursing literature, however, articles focus on the management of esophageal varices and portal hypertensive gastrointestinal bleeding with few publicat
Autor:
Roberto Hernandez-Alejandro, Cheryl Dale, Paul Marotta, William Wall, Kris P. Croome, Mark Levstik, Natasha Chandok
Publikováno v:
Transplantation Proceedings. 44:1303-1306
There is a global tendency to justify transplanting extended criteria organs (ECD; Donor Risk Index [DRI] ≥ 1.7) into recipients with a lower Model for End-Stage Liver Disease (MELD) score and to transplant standard criteria organs (DRI1.7) into re
Autor:
Khalid Alswat, Faisal M. Sanai, Kazuhiro Katada, Mohammed Alquaiz, Ahmed M. Hashem, Mayssa Saadeh, Cheryl Dale, Paul Marotta, Hussa Al-Hussaini, Hamad I. Al-Ashgar, Ahmed Helmy, Ayman A. Abdo, Hadeel AlMana, Khalid I. Bzeizi
Publikováno v:
Liver International. 31:1039-1046
Background and aim: Histological changes in hepatitis C virus (HCV)infected patients with persistently normal alanine aminotransferase (PNALT) have not been evaluated for updated upper limits of normal (ULN; 19/30 U/L for females/males). We assessed
Publikováno v:
Interfaces. 30:70-80
We solved Baxter International's IV (intravenous) systems production scheduling as a sequence-dependent scheduling problem. Unlike problems previously studied, Baxter's production line has a large number of components and parts (IV systems) with a no
Publikováno v:
Canadian Journal of Gastroenterology, Vol 23, Iss 4, Pp 265-267 (2009)
Spontaneous clearance of hepatitis C virus (HCV) is rare in immunocompromised patients, such as those who have undergone organ transplantation. It has been recognized that patients receiving liver transplantation for HCV-related disease have decrease
Publikováno v:
Alimentary pharmacologytherapeutics. 36(2)
Summary Background The role of antitumour necrosis factor-alpha (anti-TNF) therapy for inflammatory bowel disease (IBD) among liver transplant recipients is largely unknown given the rarity of this population and the paucity of literature on the subj
Autor:
Mark Levstik, William Wall, Natasha Chandok, Douglas Quan, Roberto Hernandez-Alejandro, Kris P. Croome, Paul Marotta, Cheryl Dale, Vivian C. McAlister, Mohamed Mawardi
Publikováno v:
Transplantation. 92(6)
BACKGROUND In hepatitis C virus (HCV) recipients of donation after cardiac death (DCD) grafts, there is suggestion of lower rates of graft survival, indicating that DCD grafts themselves may represent a significant risk factor for severe recurrence o
Autor:
Faisal M, Sanai, Ahmed, Helmy, Cheryl, Dale, Hamad, Al-Ashgar, Ayman A, Abdo, Kazuhiro, Katada, Hadeel, AlMana, Mayssa, Saadeh, Hussa, Al-Hussaini, Mohammed, AlQuaiz, Ahmed, Hashem, Khalid, AlSwat, Khalid I, Bzeizi, Paul J, Marotta
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 31(7)
Histological changes in hepatitis C virus (HCV)-infected patients with persistently normal alanine aminotransferase (PNALT) have not been evaluated for updated upper limits of normal (ULN; ≤ 19/30 U/L for females/males). We assessed significant fib